Accrued and Other Liabilities

12 Months Ended

Dec. 31, 2022

Accrued Liabilities and Other Liabilities [Abstract]


	December 31, 2022		December 31, 2021
Accrued liabilities
Dealer and customer allowances, claims and discounts	$	4,813	$	3,211
Deferred revenue	2,489		2,461
Product warranty and related liabilities	3,042		3,769
Payrolls and employee benefits excluding postemployment benefits	3,298		2,937
Other	11,268		7,919
Total accrued liabilities	$	24,910	$	20,297

Other liabilities
Deferred revenue	$	3,552	$	3,010
Product warranty and related liabilities	5,488		6,005
Operating lease liabilities	967		1,012
Employee benefits excluding postemployment benefits	512		622
Postemployment benefits including facility idling reserves	507		775
Other	3,740		3,661
Total other liabilities	$	14,767	$	15,085


	Years Ended December 31,
	2022		2021		2020
Product Warranty and Related Liabilities
Warranty balance at beginning of period	$	9,774	$	8,242	$	7,798
Warranties issued and assumed in period – recall campaigns	651		2,820		1,628
Warranties issued and assumed in period – product warranty	1,943		1,665		1,773
Payments	(4,097)		(3,249)		(2,986)
Adjustments to pre-existing warranties	297		315		41
Effect of foreign currency and other	(37)		(19)		(12)
Warranty balance at end of period	8,530		9,774		8,242
Less: Supplier recoveries balance at end of period(a)	1,184		2,039		224
Warranty balance, net of supplier recoveries at end of period	$	7,345	$	7,735	$	8,018

__________

(a)The current portion of supplier recoveries is recorded in Accounts and notes receivable, net of allowance and the non-current portion is recorded in Other assets.


	Years Ended December 31,
	2022		2021		2020
Product warranty expense, net of recoveries
Warranties issued and assumed in period	$	2,593	$	4,485	$	3,401
Supplier recoveries accrued in period	(261)		(2,175)		(322)
Adjustments and other	260		296		29
Warranty expense, net of supplier recoveries	$	2,592	$	2,606	$	3,108

We estimate our reasonably possible loss in excess of amounts accrued for recall campaigns to be insignificant at December 31, 2022. Refer to Note 16 to our consolidated financial statements for more details.